REVA Medical, Inc. (RVA) reported the geographic expansion of its commercial operations in seven European countries with the addition of four new distribution partnerships. These partnerships will allow REVA to expand access to its Fantom Encore drug-eluting bioresorbable scaffold, building on existing distribution partnerships and direct-selling efforts already underwayhttp://crweworld.com/article/news-provided-by-globenewswire/929463/reva-expands-geographic-footprint-to-seven-new-countries
